OBSOLETE: Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies

Oligoarticular juvenile idiopathic arthritis (JIA) with anti-nuclear antibodies (ANA) was a proposed subclassification of juvenile idiopathic arthritis that has since been marked as OBSOLETE in the Orphanet classification system (Orphanet code 247839). Oligoarticular JIA is the most common subtype of juvenile idiopathic arthritis, characterized by chronic joint inflammation affecting four or fewer joints during the first six months of disease. The presence of ANA positivity in these patients was historically noted as a distinguishing feature associated with an increased risk of chronic anterior uveitis (inflammation of the eye), younger age of onset, and a female predominance. The musculoskeletal system is primarily affected, with joints such as the knees, ankles, and wrists most commonly involved, leading to pain, swelling, and stiffness. The eyes are also at significant risk due to ANA-associated uveitis, which can lead to vision loss if not detected and treated early. This specific designation has been rendered obsolete as classification systems for JIA have evolved. Current approaches, including the International League of Associations for Rheumatology (ILAR) classification and proposed revisions by the Pediatric Rheumatology International Trials Organisation (PRINTO), have moved toward different categorization frameworks. ANA positivity is now recognized as a cross-cutting feature across multiple JIA categories rather than a defining criterion for a separate subtype. Treatment for oligoarticular JIA generally includes nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroid injections, and disease-modifying antirheumatic drugs (DMARDs) such as methotrexate. Biologic agents, particularly TNF inhibitors, may be used in refractory cases. Regular ophthalmologic screening remains essential for ANA-positive patients to detect and manage uveitis early.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about OBSOLETE: Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies